Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study: could delayed cord clamping save more newborns?

NCT ID NCT06540222

Disease control Sponsor: Region Skane Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether keeping the umbilical cord uncut for at least 3 minutes while resuscitating a newborn after an emergency C-section can improve outcomes. Researchers will compare this approach to standard care (cutting the cord quickly) in 2,200 full-term babies. The main goal is to see if fewer babies need admission to the neonatal intensive care unit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sustained cord circulation (keeping the umbilical cord uncut during resuscitation)
What this could lead to
If it works, this simple change in procedure could reduce the number of newborns needing intensive care after emergency C-section.
What could go wrong
This is a large trial, but the intervention is a procedural change, not a drug. Results may vary by hospital setting, and the benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Nov 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

37 to 42 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Singleton neonate * Born alive * Gestational age ≥37 weeks * Born by emergency cesarean section, epidural/spinal anesthesia, where the pediatric/neonatal team has been called for to attend. Exclusion Criteria: * Major congenital malformation that may affect resuscitation or outcome measures. * Major genetic disorder that may affect resuscitation or outcome measures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asphyxia neonatorum are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Fetal Hypoxia perinatal asphyxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asphyxia neonatorum Fetal hypoxia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • BB Stockholm

    RECRUITING

    Stockholm, Sweden

  • Danderyds sjukhus

    RECRUITING

    Stockholm, Sweden

  • Hallands sjukhus, Halmstad

    RECRUITING

    Halmstad, Sweden

  • Karolinska Universitetssjukhuset, Huddinge

    RECRUITING

    Stockholm, Sweden

  • Karolinska Universitetssjukhuset, Solna

    RECRUITING

    Stockholm, Sweden

  • Norrlands universitetssjukhus

    RECRUITING

    Umeå, Sweden

  • Skånes Universitetssjukhus

    RECRUITING

    Lund, Sweden

  • Skånes Universitetssjukhus, Malmö

    RECRUITING

    Malmö, Sweden

  • Södersjukhuset - Sachsska barn- och ungdomssjukhuset

    RECRUITING

    Stockholm, Sweden

  • Universitetssjukhuset i Linköping

    RECRUITING

    Linköping, Sweden

  • Universitetssjukhuset Örebro

    RECRUITING

    Örebro, Sweden

  • Östra sjukhuset - Sahlgrenska Universitetssjukhuset

    RECRUITING

    Gothenburg, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.